Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription 04.05.2025 2 Ann Intern Med 2 BMJ 1 Infect Immun 1 J Immunol 3 J Infect Dis 1 J Pediatr 2 JAMA 2 Nat Med 1 PLoS Med 7 PLoS One 19 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. BLUMENTHAL KG, Phillips EJ
   Chronic Urticaria Following HIV mRNA Vaccines: A Challenging Signal in Need of Mechanistic Insight.
   Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-25-01102.
   PubMed        
   
   
2. RIDDLER SA, Moodie Z, Clark J, Yen C, et al
   High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).
   Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-02701.
   PubMed         Abstract available
   
   

   
   BMJ

3. LOOI MK
   Trump watch: New targets include medical school accreditors, childhood covid vaccines, and more.
   BMJ. 2025;389:r850.
   PubMed        
   
   
4. MAHASE E
   Vaccine preventable diseases are making "dangerous comeback," health leaders warn.
   BMJ. 2025;389:r823.
   PubMed        
   
   

   
   Infect Immun

5. VICKERS TJ, Buckley DP, Khatoon N, Sheikh A, et al
   Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization.
   Infect Immun. 2025 May 1:e0060124. doi: 10.1128/iai.00601.
   PubMed         Abstract available
   
   

   
   J Immunol

6. JENNINGS-GEE JE, Daly CA, Bray AS, Dyevoich AM, et al
   B cell-expressed CD1d promotes MPL/TDCM lipid emulsion adjuvant effects in polysaccharide vaccines.
   J Immunol. 2025 Apr 25:vkaf074. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect Dis

7. LAI SW, Liao KF
   Herpes zoster vaccine and cardiovascular disease risk.
   J Infect Dis. 2025 Apr 30:jiaf229. doi: 10.1093.
   PubMed        
   
   
8. XU X, Ray I, Tang E, Arnold BF, et al
   Authors' reply to Herpes zoster vaccine and cardiovascular disease risk.
   J Infect Dis. 2025 Apr 30:jiaf228. doi: 10.1093.
   PubMed        
   
   
9. ATMAR RL, Lyke KE, Posavad CM, Deming ME, et al
   Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
   J Infect Dis. 2025 Apr 29:jiaf176. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Pediatr

10. EWING A, Ratner AJ
    Influenza Vaccination in the Pediatric Emergency Department: The Importance of Integrated Health Records.
    J Pediatr. 2025 Apr 26:114627. doi: 10.1016/j.jpeds.2025.114627.
    PubMed        
    
    

    
    JAMA

11. ANDERER S
    Childhood Vaccination Rates Still Lag Behind Prepandemic Levels.
    JAMA. 2025 Apr 25. doi: 10.1001/jama.2025.4675.
    PubMed        
    
    
12. ANDERER S
    Shingles Vaccine Linked to Lower Dementia Risk.
    JAMA. 2025 May 2. doi: 10.1001/jama.2025.5644.
    PubMed        
    
    

    
    Nat Med

13. PEREZ-ESTIGARRIBIA PE, Ribeiro Dos Santos G, Cauchemez S, Vazquez C, et al
    Modeling the impact of vaccine campaigns on the epidemic transmission dynamics of chikungunya virus outbreaks.
    Nat Med. 2025 May 1. doi: 10.1038/s41591-025-03684.
    PubMed         Abstract available
    
    
14. O'LEARY K
    Antibiotics reduce vaccine responses in infants.
    Nat Med. 2025 Apr 30. doi: 10.1038/d41591-025-00028.
    PubMed        
    
    

    
    PLoS Med

15. 
    Correction: Contraception use and pregnancy in women receiving a 2-dose Ebola vaccine in Rwanda: A retrospective analysis of UMURINZI vaccination campaign data.
    PLoS Med. 2025;22:e1004605.
    PubMed         Abstract available
    
    

    
    PLoS One

16. EZEZIKA O, Pellitier Z, Muhimpundu S, Daboud C, et al
    Exploring vaccination attitudes in African communities in Canada: A mixed-methods study protocol.
    PLoS One. 2025;20:e0319584.
    PubMed         Abstract available
    
    
17. VANOUDENHOVE J, Liu Y, Nelakanti R, Kim D, et al
    Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant.
    PLoS One. 2025;20:e0320744.
    PubMed         Abstract available
    
    
18. RAPAJIC-MORAN I, Filipic B, Rajkovic D, Rakic M, et al
    Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach.
    PLoS One. 2025;20:e0322584.
    PubMed         Abstract available
    
    
19. YU H, Bonett S, Oyiborhoro U, Aryal S, et al
    Correction: Psychosocial correlates of parents' willingness to vaccinate their children against COVID-19.
    PLoS One. 2025;20:e0323661.
    PubMed         Abstract available
    
    
20. HIRANBURANA N, Thippamom N, Avihingsanon A, Wacharapluesadee S, et al
    Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination.
    PLoS One. 2025;20:e0317940.
    PubMed         Abstract available
    
    
21. 
    Retraction: Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.
    PLoS One. 2025;20:e0323771.
    PubMed        
    
    
22. 
    Retraction: Immunoinformatic strategy for developing multi-epitope subunit vaccine against Helicobacter pylori.
    PLoS One. 2025;20:e0323864.
    PubMed        
    
    

    
    Vaccine

23. MOTTA M, Callaghan T, Ross JC, Gargano L, et al
    Promoting RSV vaccine confidence through reversal narrative (RN) messaging.
    Vaccine. 2025;56:127178.
    PubMed         Abstract available
    
    
24. PAUL MJ, Hudda MT, Pallett S, Groppelli E, et al
    Mucosal immune responses to SARS-CoV-2 infection and COVID-19 vaccination.
    Vaccine. 2025;56:127175.
    PubMed         Abstract available
    
    
25. WAN J, Wu M, Zhu Z, Liu X, et al
    Vaccination of a CdrA fragment conferred protection against Pseudomonas aeruginosa in wound infection via inhibition of biofilm formation.
    Vaccine. 2025;56:127185.
    PubMed         Abstract available
    
    
26. SHANKER A, Vlaev I
    The social influence of the corrections of vaccine misinformation on social media.
    Vaccine. 2025;56:127177.
    PubMed         Abstract available
    
    
27. OSEI I, Mendy E, van Zandvoort K, Sarwar G, et al
    Effect of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in rural Gambia 10 years after its introduction: A population-based cross-sectional study.
    Vaccine. 2025;56:127181.
    PubMed         Abstract available
    
    
28. BAYSAC DJ, Guay M, Chen R, Dube E, et al
    Did inequalities in COVID-19 vaccination resolve over time? Insights from the Canadian Community Health Survey.
    Vaccine. 2025;56:127153.
    PubMed         Abstract available
    
    
29. LONG Q, Wang H, He Q, Liu W, et al
    Effectiveness of rBS/WC cholera vaccine against bacterial infectious diarrhea: A test-negative study on children aged 2-6 years in Guangzhou China.
    Vaccine. 2025;56:127139.
    PubMed         Abstract available
    
    
30. MELN I, Van Molle W, Velez MP, Abrahamsen G, et al
    Advancing regulatory dialogue: In silico models for improved vaccine biomanufacturing - an expert meeting report.
    Vaccine. 2025;56:127170.
    PubMed         Abstract available
    
    
31. AGRUPIS KA, Crisostomo MV, Daag JV, Sarol J Jr, et al
    Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: Final results of a 5-year case-control study.
    Vaccine. 2025;56:127142.
    PubMed         Abstract available
    
    
32. BUSTAMANTE Q, Sparkes D, Findlater L, Munro K, et al
    Understanding occupational and attitudinal factors influencing UK healthcare worker decisions for COVID-19 and influenza vaccination: A cross-sectional survey within SIREN.
    Vaccine. 2025;56:127160.
    PubMed         Abstract available
    
    
33. LANATA CF, Ochoa TJ, Bancalari EM, Baylor NW, et al
    Testing an experimental vaccine during a public health emergency: Lessons from a Peruvian case.
    Vaccine. 2025;56:127176.
    PubMed         Abstract available
    
    
34. SUH TY, Park JH, Hwang SY, Park CR, et al
    Safety and efficacy of a Vero-adapted live attenuated vaccine candidate for African swine fever.
    Vaccine. 2025;56:127172.
    PubMed         Abstract available
    
    
35. JACOVETTY J, Wagner AL, Ichsan I, Yufika A, et al
    Associations between parental vaccine hesitancy, religion-based vaccine hesitancy, and childhood full vaccination in a cross-sectional study in Aceh, Indonesia, 2023.
    Vaccine. 2025;56:127154.
    PubMed         Abstract available
    
    
36. MELCHINGER H, Khemsara M, Ahmed N, Belgaumi SM, et al
    Assessment of mpox awareness, attitudes, and vaccination intent among the United States public following an outbreak of mpox clade Ib in Africa.
    Vaccine. 2025;56:127141.
    PubMed         Abstract available
    
    
37. OHNO M, Sekiya T, Obeng-Kyeremeh R, Handabile C, et al
    Optimization of the preparation method of inactivated intact virus particle vaccine for COVID-19.
    Vaccine. 2025;56:127173.
    PubMed         Abstract available
    
    
38. FATIMAH MNN, Thian BYZ, Wong CL, Ong HK, et al
    Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections.
    Vaccine. 2025;56:127165.
    PubMed         Abstract available
    
    
39. ESSINK BJ, Vermeulen W, Andrade C, de Rooij R, et al
    Corrigendum to 'A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older' Vaccine 51 (2025) 126791.
    Vaccine. 2025;56:127127.
    PubMed        
    
    
40. SINGLETON KL, Post DJ, Augustine AD, Ison MG, et al
    Collaborative influenza vaccine innovation centers (CIVICs) program.
    Vaccine. 2025;54:127118.
    PubMed         Abstract available
    
    
41. HANSEN BT, Kristoffersen AB, Stecher M
    Vaccination readiness among adults in Norway: A cross-sectional survey using the 7C model.
    Vaccine. 2025;56:127169.
    PubMed         Abstract available
    
    

    
    Virology

42. JIANG FY, Xia JY, Jia YJ, Zhu B, et al
    Multi-epitope microsphere vaccine modified immunological efficacy against LMBV in largemouth bass (Micropterus salmoides).
    Virology. 2025;608:110553.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.